Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nicholas Lintzeris

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 27

Top Venues

Drug and alcohol review

The Medical journal of Australia

Addiction biology

CNS drugs

South East Sydney Local Health District

Australian National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

South East Sydney Local Health District

Australia

Director :: Drug and Alcohol Services

Education History

Australian National University

Australia

PHD :: National Centre Epidemiology & Population Health

Publications

India Cordony, Llewellyn Mills, Kristie Mammen, Nicholas Lintzeris
A systematic review on the effect of routine outcome monitoring and feedback on client outcomes in alcohol and other drug treatment. Drug and alcohol review (2023)
Emma Black, Raimondo Bruno, Kristie Mammen, Llewellyn Mills, Krista J Siefried, Rachel M Deacon, Anthony Shakeshaft, Melissa A Jackson, Nadine Ezard, Mark Montebello, Steven Childs, David Reid, Jennifer Holmes, Nicholas Lintzeris
Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study. The Medical journal of Australia (2023)
Lauren A Monds, Libby Topp, Jade Pados, Jennifer Holmes, Nicholas Lintzeris
The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales. Drug and alcohol review (2023)
Robert Stirling, Suzie Hudson, Joanne Ross, Emily Deans, Joel Tibbetts, Carolyn Day, Rachel M Deacon, Melissa A Jackson, Nicholas Lintzeris
Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia. Drug and alcohol review (2023)
Lauren A Monds, Libby Topp, Jade Pados, Jennifer Holmes, Nicholas Lintzeris
The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales. Drug and alcohol review (2023)
Lauren A Monds, Libby Topp, Jade Pados, Jennifer Holmes, Nicholas Lintzeris
The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales. Drug and alcohol review (2023)
Lauren A Monds, Maria Bravo, Llewellyn Mills, Annie Malcolm, Rosie Gilliver, William Wood, Mary Ellen Harrod, Phillip Read, Suzanne Nielsen, Paul M Dietze, Simon Lenton, Anne M Bleeker, Nicholas Lintzeris
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions. Drug and alcohol review 41 (5) (2022)
Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C Arnold, Iain S McGregor
Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug and alcohol review 41 (5) (2022)
Nicholas Lintzeris, Louisa Jansen, Victoria Hayes
Response to Steele and Acheson. Drug and alcohol review 41 (5) (2022)
Hester Wilson, Michelle Schulz, Craig Rodgers, Nicholas Lintzeris, John J Hall, Ben F Harris-Roxas
What do general practitioners want from specialist alcohol and other drug services? A qualitative study of New South Wales metropolitan general practitioners. Drug and alcohol review 41 (5) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Nicholas Lintzeris, Rachel M Deacon, Victoria Hayes, Tracy Cowan, Llewellyn Mills, Laila Parvaresh, Lucy Harvey Dodds, Louisa Jansen, Raelene Dojcinovic, Man Cho Leung, Apo Demirkol, Therese Finch, Kristie Mammen
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia. Drug and alcohol review (2021)
Melissa A Jackson, Bethany White, Jillian Roberts, Michelle Cretikos, Dena Attalla, Rod Ling, Andrew Searles, Judith Mackson, Michael F Doyle, Elizabeth McEntyre, John Richard Attia, Christopher Oldmeadow, Mark V Howard, Terry Murrell, Paul Steven Haber, Nicholas Lintzeris
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction (Abingdon, England) (2021)
Thomas R Arkell, Richard C Kevin, Frederick Vinckenbosch, Nicholas Lintzeris, Eef Theunissen, Johannes G Ramaekers, Iain S McGregor
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials. Addiction biology 27 (2) (2021)
Kristie Mammen, Llewellyn Mills, Rachel M Deacon, Raimondo Bruno, Melissa A Jackson, Jennifer Holmes, Jennifer Luksza, Anthony Shakeshaft, Michael Farrell, Nicholas Lintzeris
Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions. Drug and alcohol review (2021)
Krista J Siefried, Liam S Acheson, Nicholas Lintzeris, Nadine Ezard
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review. CNS drugs 34 (4) (2021)
Bridget Oakley, Hester Wilson, Victoria Hayes, Nicholas Lintzeris
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine. Drug and alcohol review 40 (4) (2021)
Melissa A Jackson, Buddhima Lokuge, Nicholas Lintzeris
Opioid prescribing in Australia: too much and not enough. The Medical journal of Australia 215 (3) (2021)
Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, Maria Bravo, Thomas Arkell, Jonathon C Arnold, Melissa J Benson, Iain S McGregor
Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18). Harm reduction journal 17 (1) (2020)
Rachel M Deacon, Kristie Mammen, Jennifer Holmes, Melissa A Jackson, Raimondo Bruno, Llewellyn Mills, Robert Graham, Nicholas Lintzeris
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations. Drug and alcohol review 39 (5) (2020)
Llewellyn Mills, Nicholas Lintzeris, Raimondo Bruno, Mark Montebello, Adrian Dunlop, Rachel M Deacon, Jan Copeland, Meryem Jefferies, Consuelo Rivas, Kristie Mammen
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and alcohol review 39 (4) (2020)
Nicholas Lintzeris
Providing take home naloxone needs to be improved to prevent opioid overdose deaths. The Medical journal of Australia 212 (7) (2020)
Nicholas Lintzeris, Lauren A Monds, Maria Bravo, Phillip Read, Mary E Harrod, Rosie Gilliver, William Wood, Suzanne Nielsen, Paul M Dietze, Simon Lenton, Marian Shanahan, Marianne Jauncey, Meryem Jefferies, Susan Hazelwood, Adrian J Dunlop, Martina Greenaway, Paul Haber, Nadine Ezard, Annie Malcom
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives. Drug and alcohol review 39 (1) (2019)
Thomas R Arkell, Richard C Kevin, Jordyn Stuart, Nicholas Lintzeris, Paul S Haber, Johannes G Ramaekers, Iain S McGregor
Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices. Drug testing and analysis 11 (10) (2019)

Nicholas Lintzeris.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas Lintzeris